Navigation Links
Colorectal cancer: Immunological tests for more accurate detection of cancer precursors
Date:2/5/2009

A large portion of the almost 73,000 colorectal cancers diagnosed in Germany each year could be avoided. If precancerous lesions growths of the intestinal mucosa called adenomas are detected and removed at an early stage, there is a great chance that cancer will not develop at all.

Therefore, statutory health insurances in Germany offer a fecal occult blood test free of charge for all insured persons from the age of 50. This test can detect precursors of colorectal cancer. In addition, persons from the age of 55 are entitled to receive an endoscopic examination of the colon (colonoscopy) once every 10 years.

A colonoscopy identifies precancerous lesions with a certainty of over 90 percent. Nevertheless, due to reluctance to take the examination, only about 30 percent of those entitled to it actually do so (extrapolated to the 10-year period between the two colonoscopies covered by the health insurance). "Therefore, the simple laboratory tests for occult blood in the stool are still important in order to reach those who do not wish to receive a colonoscopy," explains Professor Hermann Brenner, who heads the Division of Clinical Epidemiology and Aging Research at DKFZ.

However, the widely used HaemOccult test which is covered by the health insurances has substantial disadvantages: It is less sensitive and the test result, which is based on enzymatic detection of hemoglobin, can be falsified by the patient's diet such as red meat or vitamin C supplements. By contrast, immunological detection methods are based on a very specific identification of blood components by antibodies.

In order to compare the accuracy of available tests, Brenner's team carried out a large-scale study. The epidemiologists screened stool samples of 1,319 individuals before their scheduled regular screening colonoscopy. All samples were tested with the HaemOccult method as well as with six different immunochemical tests. All methods investigated are so-called quick tests whose results can be obtained directly at any doctor's office. The test results were then compared with the results of the colonoscopies.

The researchers found out that the immunological tests were clearly superior to the HaemOccult screen in the detection of precancerous lesions. Thus, they all identified more than twice the portion of colorectal precancerous lesions. However, the immunological tests varied widely; some of the tests yielded too many "false positives". Most suitable for early detection are those tests that have a high detection rate and, at the same time, reliably give the all-clear if results are unsuspicious.

"Considering the prevalence of colon cancer, consistent screening might contribute substantially to cancer prevention," Herrmann Brenner says. "Despite the availability of colonoscopy free of charge, testing for occult blood still plays an important role, also, for example, in countries that lack the resources to offer colonoscopy to everybody. Therefore it is vital that the best available tests be used in order to improve the accuracy of stool screens. From a scientific point of view, it would be desirable for health insurances to cover the immunological tests, even though they are slightly more expensive than the common enzymatic test."


'/>"/>

Contact: Dr. Sibylle Kohlstaedt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Related medicine news :

1. Polymedco Introduces New Colorectal Cancer Educational Website
2. African-Americans have worse prognosis at colorectal cancer diagnosis
3. Hormone Therapy May Cut Colorectal Cancer Risk
4. Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps
5. Colorectal Cancer Racial Gap Still Growing
6. Screening for Colorectal Cancer Saves Lives
7. December 2008 Mayo Clinic Health Letter Highlights: Colorectal Screenings, Lighting Tips for Low Vision and Generic Medications
8. ASGE encouraged by drop in colorectal cancer deaths
9. Colorectal Cancer Screens Detect Unrecognized Disease
10. Colorectal Cancer Treatment Costs Vary Widely
11. Calcium may only protect against colorectal cancer in presence of magnesium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: